Report compares rates of sexual harassment and gendered discrimination in ophthalmology

News
Article

More respondents reported experiencing sexual harassment than in a survey conducted 5 years earlier

Symbols representing a man and a woman stand on either side of a wooden scale, which is currently balanced. Image credit: ©New Africa – stock.adobe.com

Of 287 survey respondents in 2023, 85.0% experienced gender discrimination. Image credit: ©New Africa – stock.adobe.com

A study conducted at major ophthalmology departments across the United States found that the rates of sexual harassment women experienced in the specialty, which were high when a previous survey was conducted, remained high 5 years after those high rates were disclosed, with higher frequencies of recent experiences and continued low reporting rates,1 according to Olivia J. Killeen, MD, MS, and colleagues. She is from the Department of Ophthalmology, Duke University, Durham, NC, and the Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor.

Killeen was joined in this study by colleagues from the Department of Ophthalmology, University of Washington, Seattle; the Department of Paediatrics, Duke University; the Department of Ophthalmology, Weill Cornell Medicine, New York; and the Division of Ophthalmology, Seattle Children’s Hospital, Seattle.

The investigators had a dual goal: to compare the rates and characteristics of sexual harassment in ophthalmology reported in 2018 to those described in 2023, and to investigate the rates of gender discrimination reported by the 2023 respondents. They conducted a cross-sectional, observational survey study using Google Forms through the Women in Ophthalmology email blast list from August 25 to September 25, 2023. The main study outcomes were the rates of sexual harassment, number of occurrences during the past 5 years and rates and characteristics of gender discrimination, they recounted.

Survey results

Killeen and colleagues reported that 1,051 emails containing the survey were sent; of the 692 (65.8%) that were opened, 289 were eligible participants who responded, for a response rate of 27.5% of the emails initially sent. Almost 40% of participants were from 31 to 40 years of age.

“Of the 289 survey respondents in 2023, 172 (59.5%) experienced sexual harassment in ophthalmology compared with 265 of 447 (59.3%) surveyed in 2018 (difference, 0.2%; 95% confidence interval, −7.0% to 7.5%; P = 0.95).

More respondents in 2023 experienced sexual harassment compared with 2018, ie, 62.2% versus 47.2% (P < 0.001). The investigators also found that in 2023, 24.1% reported their most severe experience to an authority compared with 15.1% in 2018 (P = 0.02). Of 287 survey respondents in 2023, 85.0% experienced gender discrimination.

In commenting on their findings, the authors said, “In this survey study, the rates of sexual harassment among respondents remained high 5 years after a survey on sexual harassment in ophthalmology, with a higher frequency of recent experiences and continued low reporting rates. With other forms of gender discrimination also highly prevalent among respondents, these results support pursuit of validated strategies to foster a culture of zero tolerance toward harassment and discrimination.”

Reference

1. Killeen OJ, Ding L, Enyedi L, Sun G, Cabrera MT. Sexual harassment in ophthalmology. JAMA Ophthalmol. Published online February 20, 2025. doi: 10.1001/jamaophthalmol.2024.6489

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.